Stock Events

Stock Events

Regulus Therapeutics (RGLS) Q4 2024 Earnings

7NovConfirmed

Q4 2023

Q2 2024

Q3 2024

Q4 2024

-0.4

-0.32

-0.23

-0.15

Details

Expected EPS

-0.169317

Actual EPS

-0.21

Surprise EPS

-0.04

Surprise Percent

+24.03%

Description

Regulus Therapeutics (RGLS) has reported earnings of -0.21 per share for Q4 2024.

0 Comments

Share your thoughts

Get the Stock Events App

Sign up for a Stock Events account to create your own watchlists and track your portfolio or dividends.